Effects of sodium-valproate administration on plasma ACTH levels in patients with ACTH hypersecretion

J Endocrinol Invest. 1983 Aug;6(4):305-6. doi: 10.1007/BF03347595.

Abstract

The effects of the acute administration of sodium-valproate (400 mg po) on plasma ACTH levels were studied in 4 patients with Cushing's disease, 1 with Nelson's syndrome and in 3 with Addison's disease. No significant reduction of corticotropin concentration was observed, as compared to saline infusion. These data do not favor the hypothesis of an inhibitory role of sodium-valproate on ACTH secretion in such patients.

MeSH terms

  • Addison Disease / blood*
  • Adrenocorticotropic Hormone / blood*
  • Adrenocorticotropic Hormone / metabolism
  • Cushing Syndrome / blood*
  • Female
  • Humans
  • Male
  • Nelson Syndrome / blood*
  • Pituitary Neoplasms / blood*
  • Valproic Acid / pharmacology*

Substances

  • Valproic Acid
  • Adrenocorticotropic Hormone